UBV
United Bank (Virginia) Portfolio holdings
AUM
$835M
1-Year Return
14.61%
This Quarter Return
-2.46%
1 Year Return
+14.61%
3 Year Return
+55.61%
5 Year Return
+104.58%
10 Year Return
+207.91%
AUM
$786M
AUM Growth
-$52.9M
(-6.3%)
Cap. Flow
-$14.5M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
45.09%
Holding
144
New
10
Increased
24
Reduced
57
Closed
8
Top Buys
| 1 |
CME Group
CME
|
+$9.02M |
| 2 |
Aflac
AFL
|
+$8.93M |
| 3 |
American Water Works
AWK
|
+$8.76M |
| 4 |
PepsiCo
PEP
|
+$8.73M |
| 5 |
Hershey
HSY
|
+$8.59M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
+$14.3M |
| 2 |
US Bancorp
USB
|
+$12.5M |
| 3 |
Pfizer
PFE
|
+$10.4M |
| 4 |
United Parcel Service
UPS
|
+$8.65M |
| 5 |
Target
TGT
|
+$7.21M |
Sector Composition
| 1 | Industrials | 22.73% |
| 2 | Technology | 14.16% |
| 3 | Financials | 11.22% |
| 4 | Healthcare | 7.72% |
| 5 | Consumer Staples | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
UnitedHealth
UNH
$319B
| $257K | 0.03% |
490
-16
| -3% | -$8.38K |
|
127
iShares Biotechnology ETF
IBB
$5.65B
| $244K | 0.03% |
1,908
| – | – |
|
128
Palo Alto Networks
PANW
$131B
| $244K | 0.03% |
1,430
-966
| -40% | -$165K |
|
129
Norfolk Southern
NSC
$61.6B
| $235K | 0.03% |
994
| – | – |
|
130
Colgate-Palmolive
CL
$67.3B
| $225K | 0.03% |
2,400
| – | – |
|
131
Zimmer Biomet
ZBH
$20.4B
| $208K | 0.03% |
+1,838
| New | +$208K |
|
132
Cincinnati Financial
CINF
$24.5B
| $207K | 0.03% |
1,403
| – | – |
|
133
Trevi Therapeutics
TRVI
$1B
| $196K | 0.03% |
31,200
| – | – |
|
134
Cardiff Oncology
CRDF
$136M
| $71.9K | 0.01% |
22,911
| – | – |
|
|
ATYR
135
aTyr Pharma
ATYR
$591M
| $41.8K | 0.01% |
+13,830
| New | +$41.8K |
|
136
Vor Biopharma
VOR
$220M
| $11K | ﹤0.01% |
15,300
| – | – |
|
137
Accenture
ACN
$149B
| – | – |
-588
| Closed | -$207K |
|
138
ASML
ASML
$320B
| – | – |
-302
| Closed | -$209K |
|
|
AUTL
139
Autolus Therapeutics
AUTL
$381M
| – | – |
-10,850
| Closed | -$25.5K |
|
140
Dow Inc
DOW
$17.7B
| – | – |
-5,240
| Closed | -$210K |
|
141
Intuit
INTU
$180B
| – | – |
-330
| Closed | -$207K |
|
142
iShares Russell 1000 ETF
IWB
$44.5B
| – | – |
-650
| Closed | -$209K |
|
143
Lineage Cell Therapeutics
LCTX
$306M
| – | – |
-12,000
| Closed | -$6.03K |
|
144
Talphera
TLPH
$19.3M
| – | – |
-14,800
| Closed | -$7.76K |
|